Weight loss study with a biological aging blood test
Part of Hormones & metabolism clinical trials.
This study looks at how a medical weight loss program affects biological aging using a simple blood test. It is for adults who are overweight or have obesity and may help show if weight loss can slow aging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 89 years old
- You are newly joining a specific medical weight loss program called NOVI OP+
- Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related health problem like prediabetes, high blood pressure, high cholesterol, sleep apnea, or heart disease
- You are not pregnant or nursing
- You have not used certain diabetes or weight loss medications (like Ozempic or insulin) in the past 3 months
- You do not have active cancer or certain mental health conditions that might affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aging and body weight affect health and metabolism. Researchers will collect detailed measurements (like scans and blood tests) to understand why some people age better than others. You may join if you are in one of five age/weight groups.
This study tests if other medicines (naltrexone, metformin, or rapamycin) can help people keep off weight they lost while taking GLP-1 drugs like Wegovy or Ozempic, after they stop taking them. It is for AgelessRx patients aged 40 to 85 who have lost at least 15 pounds on GLP-1s.
This study looks at how age affects the way your body uses insulin (a hormone that helps move sugar into cells), and how lifestyle or exercise may change that. It may help you understand insulin resistance and whether changes in activity could improve blood sugar control.
This study looks at how exercise affects hunger and weight loss in people with obesity. You'll be asked to follow a walking program while researchers monitor your weight and appetite.
This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.